GRHL2 and breast cancer: Extensive single-cell RNA sequencing showed that PDOs preserve the subclonal heterogeneity of BoM epithelial cells and show gene expression highly related to BoM, suggesting the use of breast cancer organoids to explore tumor heterogeneity and evolution, as well as precision medicine treatments (92).